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Abstract 
MRI, magnetic resonance imaging, is used for disease detection such as assessing blood 
flow, detecting tumours and diagnosing many forms of cancer.  Contrast agents are 
chemical substances that increase the MRI sensitivity. One class of contrast agents are 
the so called nanoparticulate contrast agents. Since tumour-associated formation of new 
blood vessels often results in highly permeable vessels, appropriately sized 
nanoparticles can selectively leak from the blood flow into the tumour interstitium 
and accumulate in tumours. This creates an increased difference in contrast between 
normal and abnormal tissue in an image.  
Spago Imaging AB is developing a novel and tumour specific nanoparticle based contrast 
agent. In solving the clinical evaluation of the nanoparticle it is important to know how 
the nanoparticle interacts with specific cells and tissues types. In this thesis work, an in 
vitro based assay was developed so that one aspect of the nanoparticle cell interactions 
can be studied; cellular uptake.  
The assay was developed using three reference particles, PEGylated gold nanoparticles 
and Superparamagnetic iron oxide nanoparticles (SPIO) which were in this study 
successfully functionalized with PEG1000 and APTMS. All three are known from 
literature to be internalized in certain cell lines [1-3]. HepG2 hepatocytes cells and 
human breast carcinoma cells MDA-MB-231 cells were used as models. By investigating 
the effect of cell density and amount, exposure time, nanoparticle concentration and 
particle surface characteristics, a functional assay could be set up. ICP-AES analysis and 
T1 and T2 relaxivity measurments showed that the internalization of nanoparticles 
occurred in a concentration dependant manner. The assay was used to test cellular 
uptake of a precursor of Spago Imaging AB Ion-X-gel, itself a staring material for the final 
contrast agent product. The findings indicated that the Ion-X-Gel precursor was 
internalized in a concentration dependent manner. The study also demonstrated that 
silane-coated SPIO nanoparticles possessed a higher in vitro labeling efficiency in HepG2 
cells compared to PEG coated SPIO nanoparticles. 
The results will give a better understanding of how the nanoparticles behave in a 
biological system and can in the long run help the developmental process to produce a 
product with the potential to provide more accurate diagnosis, earlier detection of 
tumours, a decrease in the number of false positives and above all, it could lead to less 
suffering for patients.  
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1. Introduction 
 
Every day, people of all ages all over the world are diagnosed with cancer. Early 
detection of tumours is important as it increases the chances for a correct and successful 
treatment meaning the possibility for full recovery is much greater. But this has proven 
to be a challenge as current methods for tumour imaging varies in effectiveness and are 
not of sufficiently high quality to meet all aspects necessary for accurate tumour 
visualization. Mammography is fast and cheap but is lacking in sensitivity, i.e. not finding 
all tumours [4]. Mammography, as well as computed tomography (CT) and positron 
emission tomography (PET), use ionizing radiation which increases the risk of cancer. 
These traditional diagnostic methods can all be harmful to normal cells and can damage 
healthy tissue [5].  
MRI is a non-invasive and quantitative method for imaging, and is considered to have a 
higher sensitivity compared to other alternatives. The downside with MRI is that it 
suffers from a high number of false positives [6]. Development of supplements that can 
increase the capabilities of the imaging tools used today is therefore important. 
Nanomaterials are such supplements. Nanoparticles as contrast agents enhance the 
contrast of structures within the body which allows for distinguish normal tissue from 
abnormal conditions in images. Spago Imaging AB is developing a novel and tumour 
specific nanoparticle (NP) based contrast agent to be used in MRI. It is necessary to gain 
understanding of if and how the particles are internalized and transported within the 
cells, and to which extent they are metabolized and excreted. The toxicity of 
nanoparticles in vivo is a concern as they can be cleared from circulation and accumulate 
in the spleen, liver or bone marrow. In order to gain knowledge of such events, in vitro 
studies of interactions between nanoparticles and various cell types with respect to 
cellular uptake is important as this could enable greater control over internalization of 
nanoparticles by the cells and thus perhaps limiting toxic effects, and increasing the 
desired effects.  
1.1. Aims 
The aim of this master thesis work was to develop and set up an in vitro based assay 
which can be used to study cellular uptake of nanoparticles. The assay is meant to be 
used to analyse cellular uptake of Spago Imagings Ion-X-gel precursor (IXG-P) and other 
nanoparticle based products. The uptake of IXG-P was expected to be low and a 
reference particle was therefore important to include in the experiments in order to 
confirm the function of the set up. Parameters such as cell density, nanoparticle 
concentration, exposure times, particle surface characteristics and different reference 
nanoparticles were to be tested as to find optimal assay conditions.  
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1.2. Magnetic resonance imaging (MRI) 
MRI uses a combination of magnetism, radio waves with different frequencies and a 
computer to produce images of body structures and organs. It is used for disease 
detection such as assessing blood flow, evaluating infections, assessing injuries to bones 
and joints, detecting tumours and diagnosing many forms of cancer [7]. MRI is based on 
the principles of nuclear magnetic resonance, NMR, a spectroscopic technique to obtain 
chemical and physical information about molecules where the interactions between 
atomic nuclei and their behaviour in a magnetic field are observed. A property of atomic 
nuclei is the intrinsic spin angular momentum which is the spinning of the nuclear 
particles around an axis at a constant rate or velocity [8]. 
The body consists of mostly fat and water which both contain hydrogen. Since 1H is the 
most abundant isotope of hydrogen, it is the natural choice for probing the body using 
MRI. All hydrogen protons have spin vectors of equal magnitude but with different spin 
orientations. When a magnetic field is applied, the net magnetization vector lies along 
the direction of the magnetic field and is called the equilibrium magnetization. By 
exposing the nuclear spin system to short pulses of radio pulses containing many 
frequencies spread over a narrow range, the net magnetization can be changed. The 
inversion recovery pulse sequence results in 180° rotation of the net magnetization 
along the Z axis after application of a pulse. A second pulse of 90° tilts the Z-
magnetization into the XY-plane (see Figure 1). 
T1 is related to the time it takes for the net magnetization to return to its equilibrium 
position along the Z axis and is called spin lattice relaxation time [8]. T2 is the time it 
takes for the transverse magnetization in the XY plane to return to equilibrium (no spin 
in XY-plane) and is called the spin-spin relaxation time. T2 relaxation emits energy and 
the signal is proportional to the population difference between the states [9].  
 
Figure 1. The effect on spin vectors when pulses in the form of radiofrequencies are applied. A) The sample is placed in a 
magnetic field (B0) and magnetization equilibrium along the Z-axis is established.  B) 180° pulse is applied resulting in 
inversion of net magnetization. C) 90° pulse is applied resulting in tilting of net magnetization. D and E) The 
magnetization is gradually returned to equilibrium.  
Determination of where in the body the energy is being released is achieved by placing 
magnetic ﬁeld gradients on the body. This enables the computer to generate a two- or 
three-dimensional map. The amount of magnetisation depends on the strength of the 
external magnetic field so higher ﬁeld strength usually allows for more detail within the 
image [10]. T1 and T2  are both tissue-specific and MRI is based on difference in the T1 
and/or T2 relaxation times of tissues [10]. Diseased or damaged tissue display 
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differences in T1 or T2 compared to normal tissue. Despite the variance in T1 and T2 
relaxation times between tissues, the difference is often not high enough for detailed 
imaging. Thus for this reason, a MRI contrast agent is often introduced to increase the 
signal difference between normal and pathological tissue [9]. 
1.3. Contrast agents 
Contrast agents used in MRI will not themselves generate any signal. Instead they act as 
indirect agents by affecting the T1 and/or T2 relaxation times of the water protons in the 
proximity of the contrast agents. Each tissue is characterised by a relaxation time T1. If 
T1 is shortened the time between the applied consecutive 90° RF pulses can be cut down 
which results in enhanced differences between the longitudinal recoveries between 
tissues with different T1 and thereby MRI sensitivity is increased. 
Many kinds of contrast agents are available, e.g. molecules containing gadolinium, 
manganese, cobalt, nickel and iron. Contrast agents can be grouped as either positive or 
negative. In general, positive contrast agents cause a reduction in T1 relaxation time. In 
an MRI image this shows as a whiter area compared to the surrounding tissue. Positive 
contrast agents are often small molecular weight compounds containing gadolinium or 
manganese. Negative agents result in shorter T1 and T2 relaxation times but with a much 
larger effect on T2. In an MRI image this shows as a darker area compared to the 
surrounding tissue. Examples of negative agents are those based on SPIO, which was 
used in this study.  
The most commonly used compounds for contrast enhancement are gadolinium-based 
[11]. Severe side effects of gadolinium can be seen in patients with renal insufficiency or 
dysfunction with risk of developing nephrogenic systemic fibrosis (NSF) [12]. NSF 
results in the fibrosis of soft and connective tissue [13] and it is progressive and may be 
debilitating or fatal. The gadolinium based chelates can rapidly distribute in the body 
leading to a short time-window for imaging and low contrast between tumour and 
surrounding tissue and limit correct diagnosis [14].  
1.4. Enhanced permeability and retention effect 
Contrary to healthy tissue, many tumours possess several unique pathophysiological 
and anatomical characteristics which results in something collectively known as the 
enhanced permeability and retention (EPR) effect. The most important characteristic is 
a high density but defective vascular architecture due to extensive angiogenesis and an 
increased production of a number of permeability mediators which leads to large gaps 
between endothelial cells in tumour blood vessels.  An impaired lymphatic 
drainage/recovery system is also characteristic  which provides a selective 
extravasation and retention of macromolecular drugs [15]. This EPR effect serves as a 
base for anticancer therapy and nanoparticle based contrast imaging as nanoparticles 
extravasate from the leaky tumour vasculature to a higher degree than healthy 
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vasculature, and remain in the tumour area. This results in a concentration difference of 
the nanoparticles in tumour tissue compared to normal tissue [16]. 
1.5. Nanoparticles 
One class of contrast agents are the nanoparticle contrast agent where the magnetic 
properties and toxicity are two of the most important parameters in the design [16]. 
Nanoparticles are smaller than cells but larger than many proteins with sizes ranging 
from one to hundreds of nanometres. The particles take advantage of the unique 
abnormalities of the tumour tissue, such as the EPR effect, to reach their target sites. 
Physiological environments such as cellular cytoplasm, blood and interstitial fluid 
contain a mixture of proteins, ions and molecules each of which may potentially interact 
with a nanomaterial. Nanoparticles can, when exposed to proteins, ions and molecules 
aggregate as these can rapidly adsorb to the nanoparticles surface. Aggregation of 
nanomaterials can affect the degree of toxicity and cellular uptake depending on the 
nanoparticles composition and the cell type [17]. In vivo toxicity of nanoparticles is a 
concern as nanoparticles can be shuttled out of circulation and accumulate in the spleen, 
liver or bone marrow via uptake by the reticuloendothelial system (RES) [1]. 
Ion-X-gel Precursor (IXG-P) 
Spago Imaging AB is developing a tumour specific nanoparticle based contrast agent. As 
a platform for the development, particles named Ion-X-gel (IXG) are used. The 
gadolinium free IXG particles consist of cross-linked polar polymers and manganese and 
the resulting product has exceptionally high relaxivity.  Manganese chelates are T1-
shortening contrast agent. Due to low toxicity and high relaxivity, manganese-based 
contrast agents display favourable properties in MRI diagnostics compared to 
gadolinium which is more toxic than Mn2+ [18]. The size of IXG (5nm) is highly 
compatible with passive tumour targeting (EPR) which makes the particle accumulate in 
the tumour tissue and be excluded by healthy tissue. One important aspect in the 
development of the particle is to study how the nanoparticles interact with biological 
systems. Of specific interest is to understand how they interact with living cells 
originating from various tissues. Such knowledge allows for further development of the 
particles with respect to e.g. excretion from the body, limiting the interaction with non-
tumorous tissue and increasing tumour targeting. IXG-P nanoparticles are the 
precursors for Ion-X-gel nanoparticles. IXG-P does not contain manganese and is 
partially composed of silicon.  
Superparamagnetic iron oxide (SPIO) 
SPIO are magnetic nanoparticle probes and they are widely utilized in biomedical 
applications, such as in vitro studies of nanoparticle uptake by cells. Both the T1 and T2 
relaxation times are shortened by SPIO, but the changes induced are dependent on the 
size of the particle, their size distribution, their coating and if they act extracellularly or 
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intracellularly [16]. SPIO have been shown to have a minimal impact on cell viability and 
function [19]. SPIO show a more extensive shortening of T1 and T2 relaxation times in 
comparison with gadolinium containing chelates [16].  
 
SPIO that are used in biochemical applications are most commonly surface modified 
with hydrophilic agents that are coated on the surface to prevent nanoparticle 
aggregation, reduce toxicity and to control pharmacokinetics and biodistribution [19]. 
When administered by intravenous injection, SPIO is predominantly cleared from 
circulation by macrophages, that reside in organs rich in reticuloendothelial cells [20]. In 
general, SPIOs are internalized by receptor-mediated endocytosis and are metabolized 
via the lysosomal pathway [20]. Iron oxide is biodegradable, and the iron from degraded 
SPIO particles is incorporated into the body’s iron store and is progressively found in 
haemoglobin, the iron-containing protein in the red blood cells [20]. SPIO was used for 
structuring the assay in this study as previous publication indicated that SPIO was 
internalized by cells [21].  
 
Gold nanoparticles (AuNP) 
The SPIOs used in this work were larger (70nm) and not of the same size range as the 
IXG-P (5 nm). Therefore a second type of molecule consisting of gold nanoparticles, in 
the same size range as IXG-P, was evaluated to be used as a positive control.  
Inorganic gold nanoconstructs are used in experimental targeted cancer therapy. They 
are the most stable and popular nanoparticles as they can be synthesized with very 
precise sizes, shapes and surface chemistries using relatively simple chemistry [22]. 
Plain gold nanoparticles have been shown to aggregate under physiological conditions 
whereas coating the AuNP with PEG has been shown to increase the stability of the 
particle [23]. Cellular uptake of gold nanoparticles is size dependent and particles with a 
smaller core diameter (30-50 nm) has been shown to be taken up by the cells to a higher 
extent compared to larger particles [23].  
1.6. Coating  
Limitations of the use of nanoparticles are still in the process of being solved. To prevent 
concerns such as nonspecific binding to nontargeted or nondiseased areas, toxicity of 
the particles on its pathway through the body as they are oxidized and degraded [16] 
and aggregation of the particle, molecules can be covalently attached or adsorbed onto 
the surface of the nanoparticles in a process called coating. The coating shields the 
nanoparticles and extends the time of circulation of the particulates from minutes to 
hours, thereby increasing the tumour targeting efficiency of a nanoparticles formulation 
capabilities [24]. Examples of coating molecules include dextran, carboxymethylated 
dextran, starches, poly ethylene glycol (PEG) and DNA [16]. The specificity of a particle 
can be increased when it is correctly coated.  
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Poly ethylene glycol (PEG) 
Some of the concerns regarding nanoparticles aggregation and absorption of plasma 
proteins is reduced by coating the particles with PEG [17].  PEG was used in this study as 
a stabilizer of SPIO and AuNP. PEG is a coiled polymer of repeating ethylene ether units 
with dynamic conformations. It has good water solubility and has the ability to dissolve 
in organic solvents. The PEG chains reduce interactions by increasing the steric distance 
between them and by increasing hydrophilicity by the hydrophilic ethylene glycol 
repeats.  PEGylated NPs generally reduce the accumulation in the liver between 25-50 % 
of the amount of non-PEGylated NPs. The size of nanoparticle can also be changed with 
PEG. 
It has been shown in previous publications that immobilization of PEG on nanoparticles 
increases the amount of uptake into cancer cells compared to unmodified nanoparticles 
[2]. This is the result of solubilisation of the particle in the cell membrane lipid layer 
mediated by PEG [25, 26].  
1.7. Endocytosis 
Nanoparticles enter the cell via endocytosis. Endocytosis is a process where invagination 
of the plasma membrane and formation of intracellular vesicles is seen. This process 
enables e.g. uptake of extracellular nutrients and entry of viruses and toxins. 
Phagocytosis and pinocytosis are different types of endocytosis. Phagocytosis involves 
the uptake of larger particles (>0.25 µm), such as bacteria, while pinocytosis involves 
the ingestion of particles via small vesicles (<0.2µm).  
The rate and mechanism of uptake of nanoparticles is cell-type dependent and varies 
with nanoparticle size, charge, and other surface properties. It is therefore difficult to 
draw general conclusions about how to produce particles for maximized or minimized 
cellular uptake. Reports have shown that nanoparticles in the range of 20–50 nm are 
taken up more rapidly compared to smaller or larger particles [27, 28].  
Endocytosis is mostly studied by using electron microscopy, fluorescently labelled 
nanoparticles and confocal microscopy. Reports have shown that internalized 
nanoparticles are found mainly in endosomes or lysosomes [29]. These organelles have 
low pH, and lysosomes contain proteases and other enzymes that degrade the particles. 
Exocytosis of nanoparticles has been studied and results indicate that this process is 
slower compared to endocytosis. The rate of exocytosis decreases with increasing 
particle size [27, 28]. 
1.8. Cell culture  
Cell culture is a major tool used in cellular and molecular biology. Due to the ability of 
culturing many cells from one batch of cells, results obtained can be reproducible and 
consistent. It provides systems for studies of toxicity and effects on cells by e.g. drugs 
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and biological compounds such as vaccines. Cell culture models can be used to e.g. 
investigate the risk of specific compounds to cause cancer in humans, to study drug 
metabolism and to monitor changes in the genome or proteome upon various stresses.  
Cells cultured in vitro often grow as monolayer on an artificial substrate that allows for 
adhesion onto the surface. Cell yield is proportional to the area of the surface where they 
are allowed to grow.  
HepG2 
A widely used cell line is the human hepatocellular carcinoma cell line HepG2. The cells 
are immortal polarized hepatocytes from the liver tissue of a fifteen year old male with 
differentiated hepatocellular carcinoma. They are epithelial-like cells growing as 
monolayers and in small aggregates. These cells are highly differentiated and display 
many of the genotypic features of normal liver cells [30]. Because they share many 
morphological and functional characteristics with cells from normal liver tissue, HepG2 
cells are used for cell-based assays of liver function, metabolism, and compound toxicity. 
HepG2 was chosen since several publications have shown to internalize SPIO 
nanoparticles [2, 31]. 
MDA-MB-231 
The cell line MDA-MB231 is a human breast carcinoma cell line with epithelial cell 
morphology and they grow in monolayer. It was derived in 1973 from a Caucasian 51 
year old woman who had received no radiotherapy. MDA-MB-231 cells were chosen as 
they have been shown to internalize SPIO nanoparticles to a lower degree compared to 
HepG2 cells [2].  
1.9. Methods for analysis 
Concentration determination of iron, silicon and gold was done with inductively coupled 
plasma-atomic emission spectrometry (ICP-AES) and UV spectrophotometry. 
Determination of T1 and T2 was done using a bench top NMR analyser.  Dynamic light 
scattering (DLS) was used to characterize the size of the different particles. For 
determination of cell , two dose-response tests were used together with an absorbance 
micro plate reader and a fluorescence microplate reader. 
ICP-AES 
ICP-AES uses the fact that as excited electrons returns to ground state they emit 
electromagnetic radiation at a given wavelength. Each element emits energy at specific 
wavelengths. The intensity of the energy emitted at the chosen wavelength is 
proportional to the amount of that element in the analysed sample. 
As the sample solution is placed into a ICP-AES it is pumped into a so called nebulizer 
where it becomes atomized into an aerosol mist. The droplets of the mist are injected 
with a stream of argon gas into ionized argon plasma. The plasma contains free 
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electrons and charged ions and the liquid droplets become ionized and are converted to 
salt particles. The salt particles are separated into molecules and will fall apart to atoms 
and ions. More energy is transferred to the atoms and ions and this procedure excites 
the valence-electrons of the elements in the sample. When the electrons return to their 
ground state at a certain position in the plasma, the relaxation emits electromagnetic 
radiation. The intensity of the radiation is proportional to the concentrations of the 
element, thus calculations can be done to obtain the exact amount of the element that is 
present in the solution. 
Relaxometry 
A bench top NMR analyser was used for T1 and T2 measurments. NMR makes use of the 
nuclei in substances as sensors of their surroundings. It is a contactless and non-
destructive analytical method as both excitation and detection are performed via 
electromagnetic waves in the radiofrequency region.   
Dynamic light scattering (DLS) 
DLS can be used to measure particle/molecular size, absolute molecular weight and zeta 
potential in the size region as low as below 1 nm. The system was used to measure the 
size of nanoparticles. It measures the Brownian motion of particles, which is the 
movement of particles due to random collisions with molecules of solvent. When 
illuminating the particles with a laser light source, the particles scatter the light with 
different intensities in all directions, known as Rayleigh scattering. The intensity 
fluctuations are analysed and the system measures the rate of intensity fluctuation and 
can from this data calculate the size of the particle [32].  
Dose-response assessment 
CellTiter AqueousOne 
For assaying dose-response a colorimetric method was used, named CellTiter 96® 
Aqueous One Solution Cell Proliferation Assay. The solution regent contains a 
tetrazolium compound which is bioreduced by cells into a coloured formazan product 
that is soluble in tissue culture medium. The conversion into the coloured formazan is 
thought to be accomplished by NADH or NADPH that is being produced in metabolically 
active cells. The quantity of formazan product as measured by the absorbance at 490 nm 
is directly proportional to the number of living cells in culture.  
An absorbance micro plate reader was used when dose-response was tested with 
AqueousOne. It uses a light beam with a specific wavelength to illuminate the samples in 
a vertical axis within a 96 well plate. A detector placed on the other side of the plate 
measures the amount of the initial light is being absorbed by the sample. The 
absorbance is proportional to the concentration of the light absorbing solution in the 
well. 
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CellTiter Blue 
Due to high standard deviations and fluctuating results using the Aqueous One dose-
response test a second test was used; CellTiter-Blue® Cell Viability Assay. The assay is 
based on the ability of viable, metabolically active cells to reduce a resazurin-based 
ﬂuorescent compound to resorufin (see Figure 2). This conversion is intracellular as 
resazurin is metabolized by mitochondrial, microsomal and cytosolic oxidoreductases to 
resoruﬁn. Resazurin itself is a nonfluorescent blue dye but when reduced to Resoruﬁn it 
becomes fluorescencent.  Resoruﬁn is detected with a ﬂuorimeter at excitation 
wavelength 560 nm. The mitochondrial activity is proportional to the total amount of 
cells, and the rate of dye reduction is therefore directly proportional to the number of 
viable cells present [33].  
 
Figure 2. The conversion of Resazurin to Resorufin.  
Fluorescence intensity detection has a broader range of applications compared to 
absorbance detection as it is more sensitive. An optical system illuminates the sample 
with a specific wavelength and the sample is thereby excited. The sample emits light 
(fluoresces) and a second optical system (emission system) collects the emitted light, 
separates it from the excitation light, and measures the signal using a light detector.  
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2. Materials and methods 
2.1. Synthesis and characterization of nanoparticles 
SPIO 
SPIO particles in an aqueous solution were purchased from Sigma-Aldrich. According to 
the product specification the SPIO concentration was 5 mg/ml with a particle size of 9-
11 nm. These particles will be referred to as A-SPIO. 
70 nm SPIO at 7 vol % magnetic iron (II,III) oxide in aqueous solution were purchased 
from ABCR in Germany.  These SPIO will be referred to as naked SPIO.  
PEGylation of SPIO 
In order to stabilize the nanoparticles, SPIO nanoparticles were mixed with PEG of three 
different molecular weights. The PEGs used were polyethylene glycol methyl ether 
(PEG500), poly ethylene glycol (PEG1000) and poly acrylic acid. PEGylation of A-SPIO 
and naked SPIO was done as follows; SPIO, PEG1000, PEG500 and polyacrylic acid were 
diluted in water. 0.2 ml SPIO at 0.165 mg/ml was mixed with 0.2 ml 700 µM, 360 µM and 
70 µM PEG1000, PEG 500 and polyacrylic acid. The mixtures were incubated overnight 
at room temperature.  
The stability of all PEGylated SPIO was examined by adding particles to H2O, saline and 
cell culture medium (DMEM and RPMI) with and without 10% FBS. The solutions were 
visually examined after 2 h incubation at room temperature. Only naked SPIO coated 
with PEG1000 (H(OCH2CH2)nOH) remained in solution indicating that these particles 
were stable. The PEGylated SPIO particle will be referred to as P-SPIO.  
Previous publications have shown that an elevated temperature (60°C) leads to partial 
dehydration of PEG molecules, permitting PEG molecules to be packed onto the NP 
surface with higher density [34]. Therefore, a solution of P-SPIO was heated for 1 h at 
60°C. This particle will be referred to as H-SPIO.  
Coating of SPIO coated with APTMS 
It is known that different coatings can affect cellular uptake. One coating which is known 
to increase cellular uptake is 3-aminopropyltrimethoxysilane (APTMS) [2]. 
Thus, naked SPIO were coated with APTMS. The amount of iron atoms that is accessible 
on the outside of the nanoparticle was estimated to 5% and the mole relationship 
between silane and surface accessible iron was calculated thereafter.  
100 µl naked SPIO was diluted with 900 µl 70% EtOH and the solution was put in a 
sonication bath for 1 h at 37°C. 2 µl concentrated APTMS was added to the naked SPIO. 
The mixture was put in an ultrasonic bath for 2 h at 37°C. The EtOH was removed by 
exposing the nanoparticle solution to a stream of nitrogen gas for 5 min by flushing the 
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gas through a glass pasteur pipette which was held just above the surface of the solution. 
The particles were then dried overnight at 50°C for removal of water. The particles were 
resuspended in 1 ml Milli-Q water and were put in sonication bath for 2 h. The solution 
was filtered through a 0.2 µm SUPOR syringe membrane (PALL) for removal of 
aggregates. The particles will be referred to as S-SPIO. 
In order to establish the presence of an APTMS coating on the S-SPIO particles, 
ninhydrin was used according to a pervious publication [35]. When the ninhydrin reacts 
with amines, a deep blue or purple colour known as Ruhemann's purple is produced. 50 
mg ninhydrin was dissolved in 200 µl 99.5% EtOH. The silanized particles were spotted 
onto a filter paper using glass capillaries and the ninhydrin solution was spotted on top 
of the spots of silanized particles. As a control, APTMS in 70% EtOH was spotted onto 
the filter paper and ninhydrin was added on top of the spot.  
Gold nanoparticles (AuNP) 
PEG coated AuNPs were provided by a co-worker at Spago Imaging AB.  
Precursor of Ion-X-gel nanoparticles 
The precursor of Spago Imaging Ion-X-gel is a 5 nm polymeric nanoparticle consisting 
mainly of silicon, phosphorus and carbon. These particles will be referred to as IXG-P. 
Size determination of nanoparticles 
Size determination of the nanoparticles was done with Dynamic Light Scattering using 
Zetasizer ZEN3600 from Malvern Instruments. Large particles, such as dust, can scatter 
light intensely and can interfere with the DLS signal from the particles. Therefore, 
samples were filtered with GHP Acrodisc 13 mm Syringe filter with 0.2μm GHP 
membrane (PALL) prior measurements. Filtered samples were measured in capped 
plastic cuvettes. The machine was programmed for 5 measurement repetitions to ensure 
that the DLS measurements were reproducible. Water was used as a blank.  
2.2. Determination of nanoparticle concentrations  
Determination of concentrations of nanoparticle stock solutions 
The concentration of iron, gold and silicon in the nanoparticle stock solutions was 
determined by ICP-AES. IPC analyses were done at Växtekologens Laboratory at the 
Department of Biology at Lunds University. The P-SPIO, S-SPIO and naked SPIO were 
sterile filtered with 0.2 µm SUPOR syringe membrane (PALL) and diluted with 12 M HCl 
to the final concentration of 5 M HCl in order to bring the iron into solution. The 
detection limit for iron with ICP analysis is 1 ppb (1µg/L). AuNP were dissolved in aqua 
regia, 12 M HCl and 15 M HNO3 (ratio 3:1), and were analysed with ICP. The detection 
limit for gold is 1 ppb (1 µg/L). Silicon content in IXG-P solution was analysed with ICP 
after the addition of 0.1% HNO3. The detection limit for silicon is 10 ppb (10 µg/L). 
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Determination of concentrations of nanoparticles in cell cultures 
Iron concentration determination 
Determination of iron concentrations in cell cultures were initially done with the 
thiocyanate method. This method proved to be too insensitive as the obtained values 
were in the same range as the detection limit. Therefore a more sensitive method based 
on ferrozine was used. Both methods are described below. However, the ferrozine 
method was also too insensitive so instead ICP analysis was used for the final 
experiments. Prior to ICP measurements the cell culture samples were mixed with 12 M 
HCl to a final concentration of 5 M.  
The thiocyanate method 
Thiocyanate reacts with Fe3+ and forms a red coloured complex, the intensity of which 
can be measured spectrophotometrically [36]. By using a solution with known 
concentration of Fe3+, a calibration curve was recorded. Different volumes of 1 mM 
FeCl3·6H2O (standard solution) was mixed with 1 M H2SO4 and 1 M KSCN in volume ratio 
1:50 to the final volume of 1 ml. Absorbance spectra was obtained from measurements 
on the solutions containing different volumes of the standard solution. Cell-based 
samples were diluted with 4 M HCl (volume ratio 1:1) and incubated overnight at 60°C, 
240 rpm on a shaking table. The samples were centrifuged for 10 minutes at 12000×g in 
order to remove macroscopic particles. The supernatant was mixed with 1 M KSCN 
(volume ratio 1:1) and 1 M H2SO4 (volume ratio 1:100) and the samples were incubated 
for 10 min at room temperature. The absorbance of the samples was measured with UV-
Spectrophotometer (UV-1800 from Shimadzu) at the absorption maximum determined 
by the calibration curve and the iron concentration in the samples could be calculated.  
The ferrozine method 
Ferrozine reacts with Fe2+ ions to form a purple-colored complex  the intensity of which 
can be measured spectrophotometrically [37]. 10 standard samples containing different 
concentrations of Fe2+ with water as diluent  (total volume 670 µl)  were mixed with 100 
µl 0.01 M ferrozine, 150 µl 30% NH2OH·HCl and 80 µl buffer consisting of 5 M 
CH3COONH4 and 4 M KOH (volume ratio 5:3). A calibration curve was obtained using the 
10 standard samples. Dilutions of cell based samples were done with 4 M HCl and the 
samples were heated for 24 h at 60°C at 240 rpm. The samples were centrifuged for 10 
min at 12000×g in order to remove macroscopic particles. The supernatant was diluted 
with 220 µl H2O + 100 µl 0.01 M ferrozine + 110 µl 4 M KOH + 150 µl 30% NH2OH⋅HCl. 
After 10 min, 80 µl 5 M CH3COONH4 (adjusted to pH 9.5 with NH4OH) was added. The 
absorbance was measured and the iron concentrations were determined.  
Gold and Silicon concentration determination  
Determination of gold concentrations in cell cultures was done by incubation with aqua 
regia, 3:1 mixture of 12 M HCl and 15 M HNO3, in order to bring the nanoparticles into 
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solution according to a previous publication [38]. Cell cultures were mixed with aqua 
regia in a volume ratio 2:3. Determination of gold concentrations was done by ICP 
analysis.  
Determination of silicon concentrations in cell cultures was done by incubation with 
KOH in order to bring the nanoparticles into solution.  Cell cultures were mixed with 4 M 
KOH in a volume ratio 2:3. The basic solution was mixed with 6 M HNO3 to a final pH of 
9. Determination of silicon concentrations were done with ICP analysis.  
Relaxivity 
Prior to preparing the cell samples for ICP analysis, T1 and T2 relaxivity was measured 
with an NMR analyser, (Minispec mq 60 from Bruker). 200 µl samples were pipetted 
into NMR glass tubes. For T1 measurements the following settings were used; 4 scans, 
pulse separation of 1 ms, recycle delay of 5 sec with duration of 10 sec. For T2 
measurements the following settings were used; 4 scans, pulse separation of 1 ms, 200 
data and recycle delay of 20 sec.  
2.3. Culturing of MDA-MB-231 and HepG2 cells  
The cells in this study were cultivated in single use sterile polystyrene flasks with 
ventilated caps with surface area of 25 cm2, 6 well plates, 24 well plates and 96 well 
plates from Nunclon and 4Titude.  
MDA-MB-231 cells were grown in RPMI-1640 with 10% FBS and 100 µg/ml 
penicillin/streptomycin. HepG2 cells were grown in medium Dulbecco's modified Eagle 
Medium (DMEM) with 10% FBS and 100 µg/ml Penicillin/Streptomycin. For culture 
initiation, 106 frozen cells were thawed. The cell suspension was then transferred to a 75 
ml culturing flask and 11 ml preheated medium was added drop wise to the flask in 
order for the cells to adjust to the environment.  
The cell cultures were split as follows; the cells were viewed with a microscope to 
confirm a good health status. The medium was aspirated. The cells were washed with 5 
ml pre-heated PBS for removal of residual medium. One ml pre-heated 0.05% trypsin 
solution was added to the cells and the flask was placed in an incubator for 5 minutes. 
The cells were examined to ensure that they had detached from the bottom of the flask. 
Nine ml pre heated medium was added and the cell suspension was pipetted over the 
flask bottom 4 times. Two ml cell suspension was moved to a fresh flask and 10 ml fresh 
medium was added. The cultures were incubated in an incubator (37 °C, 5% CO2, 95% 
humidity) for 3-4 days, where after the procedure was repeated.  
2.4. Dose-response assessment 
The dose-response was determined using two kits from Promega, CellTiter Aqueous One 
and CellTiter Blue. Dose-response tests were done on cells grown in 96 well plates. Five 
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thousand cells per well were seeded. For dose-response tests using CellTiter 96 
AqueousOne Solution, 180 µl cell suspension was dispensed into 11 columns of a 96 well 
plate (Nunclon surface). One column was left empty. For dose-response tests using 
CellTiter Blue, 90 µl cell suspension was dispensed into 11 columns in a 96 well 
OptiPlate (4Titude) and one column was left empty. The plates were incubated 
overnight prior to addition of nanoparticles.  
Preparing sample dilutions 
Prior to all dose-response tests, the particles and diluents were sterile filtered with 0.2 
µm SUPOR membrane syringe filters (PALL). The first dose-response tests were 
performed using saline as diluent. However, saline was shown in this study to have an 
aggregating effect on the nanoparticles and the saline was exchanged for Milli-Q water. 
Serial 1:2 dilutions of the nanoparticles were done in a 96 well Nunclon plate. Milli-Q 
water was used as a control. AuNP were added to wells to final concentrations ranging 
between 8.1-260 μM Au. P-SPIO concentrations ranged between 3.1-100 μg/ml iron 
oxide. Final IXG-P concentration ranged between 0.87-28 mM Si. The final 
concentrations of S-SPIO were between 0.2–200 µg/ml iron oxide. All nanoparticle 
concentrations were added to triplicate wells. The cells were exposed to the 
nanoparticles for 24 h. When using CellTiter 96 AqueousOne Solution, 20 µl of the 
nanoparticle dilutions was added to 180 µl cell suspension in the 96 well plates. When 
using the CellTiter Blue, 10 µl of the nanoparticle dilutions series was added to 90 µl cell 
suspension.  
Determining dose-resoponse  
After 24 h exposure to nanoparticles the dose-response was determined. A working 
stock of CellTiter 96 AqueousOne Solution Cell Proliferation Assay reagent was prepared 
by mixing 2 ml AqueousOne reagent with 10 ml pre heated Phenol red free RPMI 1640 
(supplemented as described above).  Phenol red was excluded as phenol red absorbs at 
the same wavelength as formazan (490 nm). The cell culture medium was aspirated 
from all wells in the 96-well plate. Each well was washed with 100 µl PBS which was 
then aspirated. One hundred µl of assay working stock was added to each well. The plate 
was incubated for 2-4 hours. An absorbance micro plate reader (Spectra Max 340 PC 
from Molecular Devices) was used to measure absorbance at 490 nm and 650 nm. One 
hundred µl working stock assay regent was used as a blank. 
When using CellTiter Blue, 20 μl of the regent was added per well without prior 
washing. The plates were incubated between 2-4 hours. The resazurin dye (blue) and 
the resorufin product (pink) are light-sensitive and prolonged exposure to light can 
result in increased background fluorescence and decreased sensitivity. Therefore the 
plates were covered in aluminium foil after reagent was added. The fluorescence signal 
was measured at 560Ex/590Em nm with a Polar Star Optima plate reader from BMG 
Labtech.  Twenty µl CellTiter Blue reagent mixed with 100 µl cell culture medium was 
used as blank.  
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Nanoparticle interference with the fluorescence signal was tested when using the 
CellTiter Blue kit. 10 µl P-SPIO particles with a concentration of 1 mg/ml and 10 µl AuNP 
with a concentration of 2.6 mM was added to 10 wells 10 min prior to measurements. 
The procedure also allowed for investigation if nanoparticle toxicity occurred instantly. 
2.5. Cellular uptake of nanoparticles 
The concentrations of nanoparticles added to the cells were based on the results of the 
dose-response tests and previous publications [2, 35, 39]. Cells were seeded in 24 well 
or 6 well plates at different cell densities but in 0.9 and 3.6 ml cell suspension 
respectively.  Cells were incubated overnight whereafter 100 µl (24 well plates) or 400 
µl (6 well plate) nanoparticle solution was added per well on the plates. Water was used 
as control. The plates were incubated at 37°C for 4 or 24 h based on previous 
publications [2]. After exposure to nanoparticles, the cells were washed 3 times with 
pre-heated PBS. One hundred µl (24 well plates) or 400 µl (6 well plates) trypsin was 
added to the wells. The plates were incubated at 37˚C for 5 minutes. One point five ml 
(24 well plates) or 6 ml (6 well plates) cell culture medium was added to all wells to 
neutralize the trypsin. The solutions were transferred to sterile Eppendorf tubes. The 
tubes were centrifuged for 5 minutes at 4500×g and the supernatant was discharged. 
The cell pellets were washed with 500 μl (24 well plate) or 2 ml (6 well plate) PBS and 
centrifuged 5 minutes at 4500×g. The cell pellets were resuspended in PBS and the cell 
density was determined using a Bürker counting chamber. The cell suspensions were 
further analysed for element concentrations and/or relaxivity. 
2.6. Prussian blue staining 
Visual confirmation of iron uptake was done using a Prussian blue staining kit (Sigma 
Aldrich). Prussian blue is a histopathology stain for detecting the presence of iron. 
Stained iron is visualized as blue or purple deposits [2, 40].  
A 96 well plate was seeded with 5000 HepG2 cells per well. Cells were incubated with 2, 
20 and 50 µg/ml P-SPIO for 24 h. After incubation the cells were washed three times 
with PBS for removal of free P-SPIO particles.  Cells were fixed with 4% 
paraformaldehyde for 40 min and thereafter washed three times with PBS. The cells 
were incubated for 10 min with Pearls reagent (4% potassium ferrocyanide and 12% 
HCl 1:1). The wells were washed three times with PBS and stained for one minute with 
neutral red and observed in a microscope.  
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3. Results and Discussion 
3.1 Nanoparticle stability 
The stability of nanoparticles can be altered depending on which solution they are 
diluted in. Instability can lead to aggregation which results in altered particle behaviour.  
A-SPIO stability 
Sedimentation was seen with A-SPIO in H2O, saline and cell culture medium with and 
without FBS indicating that these particles were very unstable. Relaxivity was measured 
on filtered and non-filtered PEGylated A-SPIO for comparison of iron content. A smaller 
amount of iron was seen in the filtered sample. Sonication (50 x 5 sec) was done on both 
solutions whereafter the solutions were viewed in a microscope. Aggregates were seen 
in both solutions. An increase in both T1 and T2 was seen over a time period of 15 
minutes with three relaxivity measurement on the same sample. This indicated 
decreasing concentrations of iron in samples with time which was confirmed by visual 
confirmation of a brown layer at the bottom of the sample tubes. The results indicated 
that PEGylated A-SPIO and the un-PEGylated A-SPIO were not stable and were therefore 
not further used. 
Naked SPIO stability 
Sedimentation of naked SPIO nanoparticles was seen in samples with saline and cell 
culture medium with and without FBS. However no sedimentation was seen in H2O. 
Sedimentation of SPIO nanoparticles coated with PEG500 and polyacrylic acid was seen 
in all solutions. This indicated that the naked SPIO, SPIO coated with polyacrylic acid and 
PEG500 were unstable.  
P-SPIO, S-SPIO, AuNP and IXG-P stability 
P-SPIO, S-SPIO, AuNP and IXG-P nanoparticles were stable in saline, H2O and cell culture 
medium with and without FBS as no sedimentations were seen.  
3.2. Size and concentration of nanoparticles 
The concentration of iron, gold and silicon in filtered stock solutions were determined 
by ICP. 
Naked SPIO nanoparticle coated with PEG1000 (P-SPIO) 
The iron concentration in filtered working stock (diluted 1:70 from 7 % original stock 
solution) P-SPIO was 53.6 mM. According to the product specification the iron 
concentration in a corresponding dilution was 64.8 mM in the non-filtered SPIO. Thus a 
small amount of iron was lost in filtration.  
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The size distribution of naked SPIO in H2O as determined by DLS ranged between 50 nm 
to 700 nm which indicated possible aggregation. The size of P-SPIO in H2O was in 
average 72 nm. When the PEG molecules were added the aggregations might have been 
dissolved, separating the P-SPIO aggregates into individual particles.  The size of P-SPIO 
in saline was larger (1184 nm) compared to in water. This indicated that the particles 
tend to form aggregates in saline though no visual confirmation of aggregates formation 
in saline was seen. Thus, dilutions were hereafter done with water. The size of the 
particles in cell culture medium with and without FBS indicated larger size of the 
particles (>100 nm) compared to the measurement in water. This phenomenon was 
most likely due to increased viscosity. Cell culture medium is more viscous than water 
and the particles therefore move slower with the effect of particles appearing larger 
than their actual size. To obtain the accurate size of the nanoparticle they were 
preferably measured in water. 
H-SPIO measured in water had an average size of 105 nm. This might be due to larger 
amounts of PEG molecules attached onto the surface of the SPIO enlarging the molecule.   
SPIO nanoparticle coated with APTMS (S-SPIO) 
The presence of APTMS coated onto the SPIO was examined by ninhydrin staining. The 
filter paper was coloured purple, which indicated that SPIO was successfully coated with 
APTMS. The iron concentration of S-SPIO was determined by ICP to be 22mg/ml. The 
size of the filtered particles was determined with DLS to be 68-78 nm. 
Gold nanoparticles   
Gold is a very unreactive metal and requires strong acid such as aqua regia to break its 
bonds and bring it into solution. ICP analysis of the AuNP indicated that the gold 
concentration of the stock solution was 26.91 mM. Size determination by DLS indicated 
that the AuNP were 10-11 nm. The coating percentage was previously calculated to be 
32% meaning that the outer surface of the particle is coated with 32% sulphur [41]. As 
each PEG was attached to two sulphurs the percentage of gold that is coated with PEG 
was 16%. 
Determination of particle loss during filtration was done by measuring an absorbance 
spectrum of a sterile filtered and non-filtered AuNP solution diluted to 130 µM in water. 
The resulting spectrum is seen in Figure 3. 
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Figure 3. Absorbance was measured on sterile filtered gold nanoparticles solution and non-filtered nanoparticles solution 
to investigate if particles were lost during filtration.  
Both solutions had an absorbance peak at 513 nm. The filtered AuNP had a nearly 
identical spectrum compared to the non-filtered AuNP which indicates that hardly any 
particles were lost during filtration. The small difference might be due to precision in 
dilution. 
Ion-X-gel precursor (IXG-P) 
The ICP analysis indicated that the silicon concentration in IXG-P was 45.5 mM. The 
concentration was too low for downstream experiments and the particles were 
concentrated by spin filtration with Amicon Ultra 10 kD filters (Millipore) at 4000×g for 
30 min. After the spin filtration, the silicon concentration was determined to 343 mM 
with ICP analysis. Size determination of the particles by DLS was not possible in water 
due to similar refraction index of the particles and water. Saline, however, has a different 
refraction index compared to the particles and the size could be determined to 4-5 nm. 
The size had previous been confirmed by co-workers at Spago Imaging AB using high-
performance liquid chromatography (HPLC). 
3.3. Dose-response assessment 
In order to establish if the nanoparticles used in this work have toxic effect on cells, dose 
response tests were performed. HepG2 and MDA-MB-231 cells were incubated with 
different concentrations of P-SPIO, H-SPIO, S-SPIO, AuNP and IXG-P nanoparticles.  
In dose-response tests using Aqueous One, a dip in cell number was seen in the most 
outer wells of the plates (see Figure 4). This was thought to be due to insufficient mixing 
of the seeding cell culture resulting in an uneven distribution of cells in the suspension. 
HepG2 cells have a tendency to aggregate and this could also create an uneven number 
of cells in the wells. In the repeated dose-response tests the cell cultures were pipetted 
repeatedly with a 1 ml pipette and the cell suspension was vortexed before being added 
to the 96 well plates in order to obtain an even distribution of cells in all wells. The cells 
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were also added to the wells in a random order and the nanoparticles were not added in 
the outer most wells. The dip was still seen but to a smaller degree. 
Comparison of CellTiter Blue and AqueousOne dose-response tests  
Dose-response tests with HepG2 cells incubated with IXG-P nanoparticles were done 
simultaneously using the two different test kits. Comparison of CellTiter Blue test and 
AqueousOne indicated that more accurate measurements were obtained with CellTiter 
Blue. Smaller standard deviations were seen with CellTiter Blue and the uneven values 
seen at the lowest concentrations of nanoparticles observed when using AqueousOne 
were not seen with CellTiter Blue. The same results were seen with all cell types both 
with and without nanoparticles. The overall dose-response appeared to be lower when 
using AqueousOne test. Stabilization was seen at 80 % with AqueousOne while 
stabilization at 100% dose-response was seen with the same concentration of 
nanoparticles using CellTiter Blue. The reason for this was unclear. Thus, CellTiter Blue 
kit was used for dose-response testing.  A comparison of CellTiter blue test and 
AqueousOne is seen in Figure 4.  
 
Figure 4. Comparison of AqueousOne and CellTiter Blue dose-response kits on HepG2 cells incubated with IXG-P 
nanoparticles. 
Nanoparticle interference with the fluorescence signal was tested when using the 
CellTiter Blue kit. The results indicated that the fluorescence signal was not affected by 
the addition of P-SPIO particles and AuNP 10 min prior to measurements (results not 
shown).  
 
MDA-MB-231 and HepG2 cells incubated with AuNP, P-SPIO and IXG-P 
Results from dose-response tests using CellTiter Blue kit with MDA-MB-231 and HepG2 
cells incubated with IXG-P, AuNP and P-SPIO are presented in Figure 5. HepG2 cells were 
less sensitive to IXG-P particles compared to MDA-MB-231 cells. Both cell lines were 
resistant to the full range of concentration of AuNP.  
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Figure 5. The dose-response of MDA-MB-231 and HepG2 cells incubated with P-SPIO, AuNP and IXG-P nanoparticles. Note 
the difference in Y-axis max. 
MDA-MB-231 and HepG2 cells incubated with P-SPIO and H-SPIO 
The dose-response of MDA-MB-231 and HepG2 cells were tested with H-SPIO using the 
AqueousOne kit. This dose-response tests was done before it was discovered that 
CellTiter Blue was a more accurate method. The results are presented in Figure 6. The 
HepG2 cells indicated no difference in cell number between the cells incubated with H-
SPIO and the cells incubated with P-SPIO. The MDA-MB-231cells were more sensitive to 
the H-SPIO compared to the P-SPIO. This might be due to difference in concentration of 
PEG molecules coated onto the surface due to elevated temperature when PEGylation of 
the particles was performed which might have led to a larger internalization of iron 
which could have toxic effects on the cells.  
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Figure 6. The dose-response of HepG2 and MDA-MB-231 cells incubated with P-SPIO and H-SPIO for 24 h. Note the 
difference in Y-axis maximum. 
HepG2 cells incubated with S-SPIO 
Dose-response tests with HepG2 cells incubated with S-SPIO particles are presented in 
Figure 7. The HepG2 cells were unaffected by all concentrations of S-SPIO.  
 
Figure 7. The dose-response of HepG2 cells incubated with S- SPIO nanoparticles. 
3.4. Cellular uptake of nanoparticles 
The aim of this part of the study was to find the optimal conditions for nanoparticle 
uptake with regards to cell density, cell culture area, nanoparticle concentration and 
harvest technique. Cells were cultured in 24 well plates or 6 well plates with different 
cell density. Cells were incubated with different concentrations of nanoparticles with 
different exposure times and the concentrations of internalized nanoparticles were 
determined. The hypothesis was that the degree of uptake would increase with 
increasing concentrations of nanoparticles. The concentrations of the nanoparticles 
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chosen in the uptake study were based on the results from the dose-response tests from 
section 3.3. and on previous publications [2, 35, 39]. 
Background control 
The iron contents in the cells were in the first uptake experiments determined by the 
thiocyanate- and ferrozine methods which are both based on the measurement of 
absorbance. First, it was investigated if debris from lysed cells could interfere with the 
absorbance measurements. MDA-MB-231 cells were harvested and prepared at a cell 
density of 106 cells/sample. Samples 1 and 2 were left untreated. P-SPIO was added in 
samples 3 and 4 in a known concentration. The samples were treated with 1:1 volumes 
of 4 M HCl and the solutions were heated for 24 h at 60°C. The following treatments 
were done; samples 1 and 3 were vortex whereafter an absorbance spectrum was 
measured both before and after centrifugation for 10 min at 12000×g. Thereafter both 
samples were mixed with 1M KSCN (volume ratio 1:1) and 1M H2SO4 (volume ratio 
1:100) and absorbance spectrum were measured for each samples again. Samples 2 and 
4 were mixed with 1M KSCN (volume ratio 1:1) and 1M H2SO4 (volume ratio 1:100) and 
absorbance spectrum were measured. Thereafter both samples were centrifuged for 10 
min at 12000×g and absorbance spectrum was measured for each sample again. The 
results are presented in Figure 8. 
 
 
Figure 8. Sample 1 and 2 did not contain P-SPIO. Sample 3 and 4 contained P-SPIO. Sample 1 and 3 were vortexed, 
centrifuged and mixed with 1M KSCN and 1M H2SO4. Sample 2 and 4 were mixed with 1M KSCN and 1M H2SO4 and 
centrifuged. Absorbance was measured after each treatment. 
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A difference in absorbance was seen between non-centrifuged and centrifuged samples 
1 and 2 indicating that rests from lysed cells could disturb measurements. Very little 
difference was seen between the two samples that were treated with KSCN and H2SO4 
after centrifugation.  
After incubation with KSCN and H2SO4, samples 3 and 4 both had an absorbance peak at 
480 nm indicating the presence of iron, but differences in absorbance were seen 
between non-centrifuged and centrifuged samples 3 and 4. This indicated that rests 
from lysed cells could disturb measurements and therefore cell suspensions were 
centrifuged prior to measurements.  
Development of nanoparticle uptake method 
After examining the toxicity of the nanoparticles on the cells, a method for studying 
nanoparticles uptake in cells was developed by finding optimal method parameters.  
Two setups using AuNPs are presented below, whereupon six setups using P-SPIO are 
presented. 
Influence of nanoparticle concentration and cell density on cellular uptake of 
AuNPs 
Setup A 
HepG2 cells were seeded in 24 well plates with a cell density of 1·105 and 7.4·105 
cells/well respectively. AuNPs were added to the cells to the final concentrations of 0.4, 
2, 10, 52, and 260 µM. The chosen gold concentrations were based on the results from 
previous publications [3, 17]. After incubation for 24 h the medium was discarded from 
the plates. For cell dissociation, trypsin/EDTA solution from Invitrogen formulated with 
0.025% trypsin and 0.01% EDTA in PBS and trypsin neutralizer consisting of calf serum 
as a trypsin inhibitor was used as this was considered a mild treatment. The 
recommended incubation time with trypsin/EDTA solution was 1-3 minutes. After 3 
minutes a large concentration of cells were still attached to the bottom of the wells and 
therefore the procedure with trypsin/EDTA and trypsin neutralizer was not used in 
further experiments. The cells were instead harvested using trypsin as described above. 
For determination of the Au concentrations, the samples were analysed with ICP. The 
results are presented in Figure 9.  
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Figure 9. Intracellular Au content in HepG2 cells at 10
5
 and 7.4·10
5
 cells/well after 24 h incubation with gold 
nanoparticles with concentrations at 0.426-260 μM. 
The desired result was an increase in uptake with increasing concentrations of AuNPs. 
The results indicated such a trend. The control wells at both cell densities contained no 
Au and a higher Au concentration was found in wells incubated with the highest 
concentrations of AuNP.  
The results indicated that the seeded cell density of 105 was too low as the amount of 
gold was close to the ICP detection limit. In the wells with seeded cell density of 7.4⋅105 
cells/well the cells were 100% confluent which indicated that this cell density was too 
high. In the following experiment the cell density was adjusted to 5⋅105 cells/well and 
three samples incubated with the same concentrations of AuNPs were pooled. 
Setup B 
HepG2 cells were cultured at a cell density of 5·105 cells/well in a 24 well plate. AuNPs 
were added to cell cultures to the final concentrations of 100, 20, 2 μM in nine wells per 
concentration. After incubation overnight, three wells per concentration were pooled 
prior to determination of the gold content in order to increase the gold concentrations in 
the samples. In addition, since each concentration was done in triplicate, standard 
deviations could be calculated. For determination of the Au concentrations, the samples 
were analysed with ICP. The results are presented in Figure 10. 
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Figure 10. Intracellular Au content in HepG2 cells with 5·10
5
 cells/well after 24 h incubation with gold nanoparticles with 
concentrations at 2-100 μM. 
It was indicated that the cells were able to take up AuNPs of a size of 10 nm in a 
concentration dependent manner.  
During uptake experiments with AuNPs, publications were found that included 
PEGylated gold nanoparticles as negative controls for cellular uptake, as it has been 
demonstrated that these do not bind to a variety of cancer cell lines in the absence of a 
specific targeting ligand [23]. Other publications have indicated that PEGylated AuNPs 
were taken up to a very low extent compared to other types of coatings [3]. Studies have 
also shown that uptake of AuNPs changed cellular morphology, increasing cell size and 
inducing apoptosis in cells [42]. The choice of using AuNP as a positive control in future 
experiments with other cell types can therefore be questioned. The AuNPs were not 
used in further experiments. 
Influence of nanoparticle concentration, cell density and incubation time on 
cellular uptake of iron oxide nanoparticles 
Setup A 
The following parameters were used; HepG2 cells in a 24 well plate with seeding cell 
densities of 5·103, 1·104 and 1·105 cells/well. Incubation was done with P-SPIO 
nanoparticles with the final concentrations of 100, 50, 10, 4, and 2 μg/ml. After 
harvesting the cells, the cell pellets were resuspended in DMEM cell culture medium. 
The iron concentrations were determined with the thiocyanate method.  
Iron was detected in the control samples indicating that there was a presence of iron in 
the medium. According to the manufacturer, DMEM contained 100 µg/ml Fe(NO3)3. In 
the following experiments the DMEM was replaced with PBS for resuspension of the cell 
pellets. 
Other things were also observed. The cells were larger in the wells with the cell density 
105 cells/well compared to the cells seeded at 104 and 5⋅103 cells/well. The reason for 
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this was unknown. More cell aggregates were observed in wells with seeded cell 
densities 104 and 105 cells/well compared to 5⋅103 cells/well. 
In the following experiment, the cell pellets were resuspended in PBS and the cell 
density was increased to 1·105 and 7.4·105 cells/well. 
Setup B 
The following parameters were used; HepG2 and MDA-MB-231 cells were seeded in 24 
well plates with seeding cell density of 1·105 and 7.4·105 cells/well. P-SPIO was added to 
the cells to the final concentrations of 100, 50, 10, 4, and 2 μg/ml and the plates were 
incubated. After harvesting of cells, the cell pellets were resuspended in 200 µl PBS.  The 
iron content was determined with the thiocyanate method. The results are presented in 
Figure 11. 
 
 
Figure 11. (Top left panel) Intracellular iron content in HepG2 cells with cell density at 10
5
 cells/well after 24 h incubation 
with P-SPIO with concentrations ranging between 2-100 μg/ml. (Top right panel) Intracellular iron content in HepG2 cells 
with cell density at 7.6·10
5
 cells/well after 24 h incubation with P-SPIO with concentrations ranging between 2-100 
μg/ml. (Left bottom panel) Intracellular iron content in MDA-MB-231 cells with cell density of 10
5
 and 7.4·10
5
 cells/well 
after 24 h incubation with P-SPIO with concentrations ranging between 2-100 μg/ml. 
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Nanoparticle uptake with seeded cell density of 7.4⋅105 cells/well with both HepG2 and 
MDA-MB-231 cells indicated a tendency of concentration dependent uptake of P-SPIO. A 
higher uptake of iron was seen with higher concentrations of P-SPIO. In the wells with 
HepG2 cells seeded at 105 cells/well, the amount of cells after incubation with the 
highest concentration of P-SPIO, was 30% of the average amount of cells in the other 
wells. With MDA-MB-231 cells seeded at of 105 cells/well, the amount of cells after 
incubation with the highest concentration of P-SPIO was 80% of the average amount of 
cells in the other wells with MDA-MB-231 cells. This could indicate toxicity and 
therefore the calculated value of iron per 105 cells was misleading since the amount of 
cells was lower in these wells compared to the other wells.  
A comparison between the two cell types, seeded with 105 cells/well, indicated that 
MDA-MB-231 cells internalized iron in a lower degree compared to HepG2 cells which 
correlated to previous publications [2]. This was not seen in cultures with a cell density 
of 7.4·105 cells/well.  
The hypothesis that the degree of uptake would increase with increasing concentrations 
of P-SPIO was not consistent with a cell density of 105 cells/well. The iron 
concentrations were close to the detection limit of the thiocyanate method and were 
therefore not reliable. This could be due to too low cell density in relation to the 
concentration of P-SPIO. P-SPIO might have a too high impact on the low number of cells. 
In the wells with the cell density of 7.4·105 cells/well, the monolayer was 100% 
confluent. However, the total number of cells per well was lower than expected and this 
might be due to lack of surface area for attachment in relationship to the amount of cells 
indicating that the cell density was too high. However, at this cell density a tendency to 
an increase of intracellular iron was seen with increasing concentrations of P-SPIO, 
except for the highest incubation concentration at 100 µg/ml. 
The results indicated that the seeded cell density of 105 cells/well was too low as the 
amount of iron was again close to detection limit. In the wells with seeded cell density of 
7.4⋅105 cells the monolayer was 100% confluent which indicated that this cell density 
was too high. In the following experiment (see below) the cell density was adjusted to 
3⋅105 and 5⋅105 cells/well and the samples were done in triplicate and they were pooled 
in an attempt to find the optimal cell density for attachment of all cells and cell amount 
large enough for obtaining detectable levels of iron.  
Setup C 
MDA-MB-231 cells were seeded with cell densities of 3·105 and 5·105 cells/well. The 
cells were incubated for 4 h with P-SPIO at concentrations between 0.5-50 μg/ml. HepG2 
cells were seeded with same cell density as MDA-MB-231 but they were exposed to the 
nanoparticles for 24 h. Due to a calculation error the P-SPIO concentration of 50 μg/ml 
was not included in the setup. The concentrations of P-SPIO were instead 0.5-5 μg/ml. 
Concentration determination was done with the thiocyanate method. The results are 
presented in Figure 12.  
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Figure 12. (Left panel) Intracellular iron content after 4 h incubation with SPIO concentrations at 0.5-50 μg/ml at 37°C in 
MDA-MB-231 cells with cell density of 3·10
5
 and 5·10
5
 cells/well (Right panel) Intracellular iron content after 24 h 
incubation with SPIO concentrations at 0.5-5 μg/ml at 37°C in HepG2 cells with cell density of 3·10
5
 and 5·10
5 
 cells/well. 
The amount of intracellular iron in all MDA-MB-231 cell samples was very low and did 
not correlate with the concentration of added P-SPIO. In addition, the amount of 
intracellular iron in the control cells was equal that of the cells incubated with P-SPIO. 
This might be due to an insufficient amount of cells used in the study since the resulting 
iron concentrations were very close to detection limit. The short exposure time could 
also contribute to the low concentrations, but since a longer exposure time using HepG2 
cells gave similar results with the cell density 3⋅105 cells/well, the exposure time is most 
likely not the limiting factor. This was confirmed in pervious publication [39] which 
indicated that iron oxide complexes were attached to the surface rather than 
internalized after 4 h exposure. Thus, a nanoparticles exposure time of 4 h was not 
investigated any further. In the wells with HepG2 seeded at 5⋅105 cells/well, the uptake 
followed a concentration dependent trend. However, the background was still high in 
the control samples.  In these wells the cell monolayer had not reached 100% 
confluency, indicating that enough surface was available for attachment for all the cells 
at this cell density.   
Setup D 
HepG2 cells were seeded in 24 well plates with a cell density of 3·105 cells/well. It was 
not possible to test a cell density of 5·105 cells/well as the amount of cells in the culture 
flasks were too low. P-SPIO was added to wells in triplicates at 0.5, 5 and 50 µg/ml 
whereafter the plates were incubated. Concentration determination after harvesting of 
the cells was done with the thiocyanate method. The results are presented in Figure 13. 
Despite the increased cell amount, the values were close to the detection limit and could 
therefore not be trusted. The result with the HepG2 cells were similar to the previous 
experiments (see above) in that the uptake of iron seemingly increased with increasing 
P-SPIO concentrations. Unfortunately, the iron concentration in the control cells was too 
high.  
0
2
4
6
8
10
12
5050,5control
n
m
o
l F
e
/1
0
0
0
0
0
 c
e
lls
  
 [P-SPIO] (µg/ml) 
MDA-MB-231 (4 h) 
0
2
4
6
8
10
12
50,5control
n
m
o
l F
e
/1
0
0
0
0
0
 c
e
lls
 
[P-SPIO] (µg/ml) 
HepG2 (24 h) 
300000 cells
500000 cells
33 
 
 
Figure 13. Intracellular iron content in HepG2 cells with cell density of 3·10
5
 cells/well after 24 h incubation with P-SPIO 
with concentrations at 0.5-50 μg/ml. 
Setup E 
Simultaneously as the previous experiment with HepG2 cells was done (Attempt D) the 
same parameters were tested on MDA-MB-231 cells in 24 well plates but also including 
an experiment in 6 well plates.  Cells were seeded at 3·105 and 5·105 cells/well in 24 well 
plates together with 6 well plates with 1·106 cells/well. P-SPIO was added to the wells 
with final concentrations from 0.5-50 μg/ml. Iron concentrations were determined with 
the thiocyanate method. The results are presented in Figure 14.  
 
Figure 14. Intracellular iron content in MDA-MB-231 cells with cell density of 3·10
5
 and 5·10
5
 cells/well in a 24 well plate 
and 6 well plate with a cell density of 1·10
6
 cells/well after 24 h incubation with P-SPIO with concentrations at 0.5-50 
μg/ml.  
The resulting iron concentrations were very close to the detection limit. The control 
samples for the cells seeded at 3·105 and 5·105 cells/well had high iron concentrations. It 
was assumed that the cell density was too low for obtaining detectable iron amounts. 
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The iron concentrations in the 6 well plates were not reliable as the concentrations were 
very close to the detection limit.  
Comparison between the two cell type in 'Attempt D' and 'Attempt F' with cell density of  
3·105 cells/well incubated with 50 μg/ml P-SPIO indicated that MDA-MB-231 cells 
internalized iron to a lower degree compared to HepG2 cells which correlated with 
previous publications [2].  
In the following experiment (Attempt F) a cell density of 5·105 cells/well was used as the 
cells at this cell density had the ability of proliferating in a non-inhibiting way. Pooling of 
samples incubated with the same concentration of P-SPIO was done in order to obtain 
detectable amounts of iron.  
Setup F 
HepG2 cells were seeded in 24 well plates with a cell density of 5·105 cells/well. P-SPIO 
was added to wells in triplicates per iron concentration. After harvesting of cells, 
triplicates were pooled in order to increase the iron concentration. The iron 
concentration was determined with the ferrozine method. The amount of iron was 
below detectable levels and no results were obtained.  In the following experiments the 
concentrations of iron were increased by pooling of five samples, and the samples were 
analysed with ICP.   
The successful assay setup 
HepG2 cells were seeded in 24 well plates with a cell density of 5·105 cells/well. P-SPIO 
was added to the final concentration of 50, 20 and 2 μg/ml in 15 wells per 
concentration. Following exposure and cell harvest, 5 samples per concentration were 
pooled giving triplicates for each concentration. The samples were analysed for T1 and 
T2 relaxivity and iron content. ICP analysis was more sensitive in determination of low 
iron concentrations and therefore this method was used instead of the thiocyanate and 
the ferrozine method. The results are presented in Figure 15. The iron concentrations 
were well above the ICP detection limit which indicated that the results were reliable.  
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Figure 15. Intracellular iron content in HepG2 cells with cell density of 5·10
5
 cells/well in a 24 well plate after 24 h 
incubation with P-SPIO with concentrations at 2-50 μg/ml at 37°C. In the left panel one of the triplicate samples at 50 
μg/ml P-SPIO was excluded. See text for further discussion. 
The results indicated a clear increase of uptake of iron in HepG2 cells with increasing 
incubation concentration of P-SPIO. The highest uptake was seen with the P-SPIO 
concentration of 50 μg/ml. No effect on cell number was seen at this concentration as 
the number of cells counted in these wells was equal to the number of cells counted in 
the control wells. One of the triplicates from the wells incubated with 50 μg/ml  was 
excluded in the left panel in Figure 14 as this had a substantial higher iron content 
compared to the other two samples with the same incubation concentration. After 
communication with the staff at the ICP lab it was concluded that this could be due to 
iron contaminants from calibration samples in the machine at the ICP lab. On the right 
panel in Figure 14 the outlier at 50 µg/ml is included. 
T1 and T2 relaxivity were also measured on cell samples prior to ICP analysis (see Figure 
16). Both T1 and T2 increased with decreasing incubation concentrations of P-SPIO. This 
indicated that the intracellular iron content was increased with increasing incubation 
concentrations of P-SPIO.   
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Figure 16. The T1 (left) and T2 (right) were measured on HepG2 cells incubated with concentrations of SPIO between 2-
50µg/ml. Water was used as a control. A higher T value indicates a lower iron concentration in the sample. 
The experiment described above was repeated with the same parameters to confirm the 
results. Iron concentrations were determined with ICP. Results are presented in Figure 
17.  
Particles can be attached to the outer membrane of the cells, without particle uptake. 
This may result in faulty iron values and to rule out particle contamination the following 
procedure was done; 10 minutes before the cells were harvested, P-SPIO was added to 
wells in the 24 well plates to a concentration 50 µg/ml. No iron was detected in the cells 
(see Figure 17). 
 
Figure 17. Intracellular iron content in HepG2 cells seeding at 5·10
5
 cells/well after 24 h incubation with P-SPIO with 
concentrations at 2-50 μg/ml with water added as control. Contamination of cells with particles was investigated with 
addition of P-SPIO 10 minutes prior to cell harvesting (negative control). 
The iron content in the cells was lower compared to the previous experiment (see 
Figure 16) but the trend was similar. The ICP laboratory suggested that an error could 
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have been made at the lab when diluting the samples prior to analysis. The standard 
deviation did overlap with the concentrations at 20 and 2 μg/ml but as the control did 
not contain any iron the results were considered reliable. The potential dilution error at 
the ICP lab was strengthened with the results from the T1 and T2 measurments (see 
Figure 18) which resulted in similar relaxation values as the previous experiment. 
Internalization of iron was seen in a concentration dependent manner.  
  
Figure 18. The T1 (left) and T2 (right) were measured on HepG2 cells incubated with concentrations of SPIO between 2-50 
µg/ml. Water was used as a control.  
The values of T1 and T2 in the samples tested with P-SPIO particles added just prior to 
the harvesting of cells were similar to the water control indicating that no iron 
contamination occurred (results not shown).  
The experiments resulted in detectable internalization of P-SPIO in HepG2 cells, 
indicating that the P-SPIO particles could be used as positive control in further 
experiments. The amount of iron content in the cells incubated with P-SPIO at 50 µg/ml 
correlates well to previous publications [39, 43, 44]. P-SPIO nanoparticles at an 
incubation concentration of 50 µg/ml were used as a positive control in following 
experiments using the same set up but with other nanoparticles. 
Prussian Blue staining 
Prussian Blue staining was done to visually confirm the intercellular location of 
internalized iron. Accumulation of iron was seen as black spots (see Figure 19) in the 
cytoplasm of HepG2 cell incubated with 50 µg/ml P-SPIO. In which organelle the 
accumulation occurred was not determined. These accumulations were not seen in the 
cells incubated with lower concentrations of P-SPIO or in the control cells. This was an 
indication of the ability of HepG2 cells to take up P-SPIO and it supports the results in 
the adsorption test, i.e. that nanoparticles are not adsorbed to the surface of the cells. 
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Figure 19. Accumulation of iron is seen as a black spot in the cytoplasm of the HepG2 cell (left). No accumulation of iron 
was seen in control cells without any SPIO (right). 
Uptake of S-SPIO 
To compare how different coatings affect the degree of uptake, HepG2 cells were 
exposed to S-SPIO and P-SPIO. Six well plates with HepG2 cells were prepared with a 
seeded cell density of 2.5·106 cells/well. P-SPIO and S-SPIO were added to wells in 
triplicates to the final concentrations of 50 μg/ml. Cells were harvested after 24 h and 
the pellets were resuspended in PBS and the cells were counted. ICP analysis was not 
performed on the samples. Instead T1 and T2 were measured on the cell suspensions (see 
Figure 20). The results indicated higher iron content in cells incubated with S-SPIO 
compared to cells incubated with P-SPIO.  
 
Figure 20. The T1 (left) and T2 (right) were measured on HepG2 cells incubated with silanized and P-SPIO at 50 µg/ml. 
Water was used as a control.  
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Uptake of IXG-P 
When the method for studying cellular uptake was established it was used to investigate 
if HepG2 cells had the ability of internalize Spago Imagings Ion-X-Gel precursor. HepG2 
cells were cultured at a cell density of 5·105 cells/well in a 24 well plate. IXG-P particles 
were added to 15 wells per concentration to the final concentration of 15, 7.5 and 2 mM 
silicon. Fifty μg/ml P-SPIO was used as reference. Following exposure and cell harvest, 5 
samples were pooled giving triplicates of each concentration. The silicon and iron 
content was determined by ICP analysis. Results are presented in Figure 21. 
 
Figure 21. Intracellular silicon content in HepG2 cells after 24 h incubation with different concentrations of IXG-P 
nanoparticles. P-SPIO nanoparticles with a concentration of 50 µg/ml were used as reference particles (results not 
shown).  
The uptake of IXG-P occurred in a concentration dependent manner. As incubation 
concentrations with IXG-P particles increased the concentration of internalized 
nanoparticles increased. The iron content in the cells incubated with P-SPIO was 
measured. The iron content was in the same range as in previous trials, 1.1 µmol/105 
cells (see 'successful assay setup') confirming the function of the set up and the cells 
ability to internalize nanoparticles. This indicated that HepG2 cells had the ability to 
internalize IXG-P nanoparticles. 
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4. Conclusions 
 
In the presented thesis an in vitro based assay was developed for studying cellular 
uptake of nanoparticles. The assay was used to analyse the interaction between IXG-P 
and HepG2 cells with respect to cellular uptake. Reference nanoparticles to be used as 
positive controls needed to be included in the experiments in order to confirm the 
function of the set up. Three different reference nanoparticles were investigated. 
Superparamagnetic iron oxide nanoparticles (SPIO), which were modified with PEG and 
APTMS, and PEGylated gold nanoparticles.  The dose-response of HepG2 and MDA-MB-
231 cells incubated with the three different nanoparticles including IXG-P was tested. 
The dose-response tests indicated at which nanoparticles concentrations the particles 
were toxic to the cells. Two dose-response kits were used, CellTiter Blue and 
AqueousOne. The use of CellTiter Blue kit was preferred as this method gave lower 
standard deviations and it was more cost efficient compared to the AqueousOne kit. 
Method development for studying uptake of nanoparticles in HepG2 and MDA-MB-231 
cells was based on the results of the dose-response tests and results from previous 
publications. Parameters such as cell density, nanoparticle concentration and exposure 
time to the nanoparticles were changed in different setups in order to ultimately achieve 
detectable and repeatable uptake of the nanoparticles in the cells.  
The internalization of 70 nm PEGylated SPIO and 10 nm gold nanoparticles was seen in 
HepG2 cells in a dose dependent manner with the following parameters;  
 24 well plates with seeded cell density of 5⋅105 cells/well  
 exposure time of nanoparticles for 24 h 
 using trypsin for harvesting of the cells  
 resuspension of the cell pellets in PBS 
 pooling of 5 samples  following harvesting of cells 
 concentration determination using ICP-AES  
The concentration of the internalized PEGylated SPIO was preferably determined with 
ICP-AES as this method was more sensitive with lower detection limit in comparison 
with the thiocyanate- and the ferrozine methods where the detection limits were too 
high. The major difﬁculty with ICP-AES is the associated higher cost. The uptake of 
PEGylated SPIO was also confirmed with relaxivity measurments, where the values of T1 
and T2 increased with decreasing incubation concentrations of P-SPIO. This indicated 
that the iron contents in the cells increased with increasing incubation concentrations of 
P-SPIO. The highest uptake in HepG2 cells was seen with incubation concentration of 50 
µg/ml P-SPIO. The intercellular location of iron was visually confirmed with Prussian 
Blue staining.  
The results indicated that a successful method for studying uptake of nanoparticles 
using PEGylated SPIO at a concentration at 50 µg/ml as a positive control was achieved. 
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The internalization of the IXG-P with the size of 5 nm was tested in HepG2 cells using the 
PEGylated SPIO particles as a positive control. IXG-P was internalized in a dose 
dependent manner. A comparison of uptake between silanized and PEGylated SPIO was 
tested in HepG2 cells. The results indicated a higher uptake of the silanized SPIO 
particles compared to the PEGylated SPIO particles.  
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5. Proposed future work 
 
The rate, mechanism and the degree of internalization of nanoparticles have been 
indicated to be very cell-type dependent and varies between nanoparticles depending 
on their size, charge, and other surface properties [25]. Publications have indicated that 
non coated SPIO particles are internalized by tumour cells at a lower degree compared 
to coated SPIO particles [31]. It has also been indicated that PEG coating can both 
facilitate the uptake of iron and decrease the uptake depending on the cell type. 
Different PEG molecules differ in size and the type of PEG chosen as coating molecule 
can result in difference in uptake. Therefore, different coatings of SPIO can be evaluated 
in future studies such as other PEG molecules, silane molecules or dextran in order to 
increase the internalization of iron to obtain values that can be detected using the 
thiocyanate- or ferrozine method. Some reports have indicated that coated 
nanoparticles are internalized in a lower degree compared to non-coated particles, and 
therefore further investigation of internalization of naked particles are of interest.  
A large amount of cells was required in this study in order to obtain detectable amount 
of internalized iron. The cells can in future studies be cultured in wells with larger 
adhesion area, such as 6 well plates, for easier and less time consuming harvesting 
procedure. Parameters such as exposure time of nanoparticles can be changed as one 
publication has indicated that a maximum uptake was seen after 4 days of exposure to 
nanoparticles [26]. If internalization is further optimized, fewer cells could be used 
which would facilitate the procedure. 
The method developed in this work can be used with other cell types such as THP-1 
(human acute monocytic leukemia), RAW264 (mouse leukemic monocyte-
macrophages), MDA-MB-436 (human breast adenocarcinoma) and JURKAT (T cell 
leukemia) to gain information of the interaction between IXG-P and other tumour cell 
types.  Using the same methodology, the uptake of nanoparticles can also be studied in 
primary cell lines such as HUVEC (Human Umbilical Vein Endothelial Cells), HASMC 
(Human Aortic Smooth Muscle Cells) and HMEC (Human Mammary Epithelial Cells).  
The knowledge gained from this study can be used for further development of the 
particle developed at Spago Imaging AB with respect to e.g. limiting the interaction with 
non-tumorous tissue and increasing tumour targeting. 
  
43 
 
References 
 
1. Jokerst, J.V., et al., Nanoparticle PEGylation for imaging and therapy. Nanomedicine, 2011. 
6(4): p. 715-728. 
2. Zhu, X.-M., et al., Enhanced cellular uptake of aminosilane-coated superparamagnetic iron 
oxide nanoparticles in mammalian cell lines. International Journal of Nanomedicine, 2012. 7. 
3. Freese, C., et al., Size- and Coating-Dependent Uptake of Polymer-Coated Gold Nanoparticles 
in Primary Human Dermal Microvascular Endothelial Cells. Biomacromolecules, 2012. 13(5): 
p. 1533-1543. 
4. Sardanelli, F., et al., Sensitivity of MRI versus mammography for detecting foci of multifocal, 
multicentric breast cancer in fatty and dense breasts using the whole-breast pathologic 
examination as a gold standard. American Journal of Roentgenology, 2004. 183(4): p. 1149-
1157. 
5. Huang, B., M.W.-M. Law, and P.-L. Khong, Whole-Body PET/CT Scanning: Estimation of 
Radiation Dose and Cancer Risk. Radiology, 2009. 251(1): p. 166-174. 
6. Berg, W.A., et al., Detection of Breast Cancer With Addition of Annual Screening Ultrasound 
or a Single Screening MRI to Mammography in Women With Elevated Breast Cancer Risk. 
Jama-Journal of the American Medical Association, 2012. 307(13): p. 1394-1404. 
7. Stanford medicine, C.i. 2013; Available from: cancer.stanford.edu. 
8. Joseph P. Hornak, P.D., The Basics of MRI. 1996, Rochester, N.Y. :Rochester Institute of 
Technology. 
9. Lee, G.H., Y. Chang, and T.J. Kim, Blood-Pool and Targeting MRI Contrast Agents: From Gd-
Chelates to Gd-Nanoparticles. European Journal of Inorganic Chemistry, 2012(12): p. 1924-
1933. 
10. Brown, M.A. and R.C. Semelka, MRI: Basic Principles and Applications. Vol. 4th ed. 2010: 
Wiley- Blackwell. 1-27. 
11. Weinmann, H.J., et al., Tissue-specific MR contrast agents. European Journal of Radiology, 
2003. 46(1). 
12. Administration., U.S.F.a.D. Important drug warning for gadolinium-based contrast agents. 
2007; Available from: 
http://www.fda.gov/downloads/Safety/MedWatch/SafetyInformation/SafetyAlertsforHuma
nMedicalProducts/UCM154532.pdf. 
13. Tan, M., et al., Synthesis and Evaluation of Nanoglobular Macrocyclic Mn(II) Chelate 
Conjugates as Non-Gadolinium(III) MRI Contrast Agents. Bioconjugate Chemistry, 2011. 
22(5). 
14. AB, S.I. 2012  [cited 2013 2013-01-15]; Available from: www.spagoimaging.com. 
15. Fang, J., H. Nakamura, and H. Maeda, The EPR effect: Unique features of tumor blood vessels 
for drug delivery, factors involved, and limitations and augmentation of the effect. Advanced 
Drug Delivery Reviews, 2011. 63(3): p. 136-151. 
16. Hofmann-Amtenbrink, M., H. Hofmann, and X. Montet, Superparamagnetic nanoparticles - a 
tool for early diagnostics. Swiss Medical Weekly, 2010. 140. 
17. Albanese, A. and W.C.W. Chan, Effect of Gold Nanoparticle Aggregation on Cell Uptake and 
Toxicity. Acs Nano, 2011. 5(7). 
18. Murph, S.E.H., et al., Manganese-gold nanoparticles as an MRI positive contrast agent in 
mesenchymal stem cell labeling. Journal of Nanoparticle Research, 2012. 14(4). 
19. Kresse, M., et al., Targeting of ultrasmall superparamagnetic iron oxide (USPIO) particles to 
tumor cells in vivo by using transferrin receptor pathways. Magnetic Resonance in Medicine, 
1998. 40(2). 
20. Elias, A. and A. Tsourkas, Imaging circulating cells and lymphoid tissueswith iron oxide 
nanoparticles. 2009, American Society of Hematology: Department of Bioengineering, 
University of Pennsylvania, Philadelphia. p. 720-726. 
44 
 
21. Lin, C., S. Cai, and J. Feng, Positive Contrast Imaging of SPIO Nanoparticles. Journal of 
Nanomaterials, 2012. 
22. Daniel, M.C. and D. Astruc, Gold nanoparticles: Assembly, supramolecular chemistry, 
quantum-size-related properties, and applications toward biology, catalysis, and 
nanotechnology. Chemical Reviews, 2004. 104(1). 
23. Arnida, A. Malugin, and H. Ghandehari, Cellular uptake and toxicity of gold nanoparticles in 
prostate cancer cells: a comparative study of rods and spheres. Journal of Applied Toxicology, 
2010. 30(3). 
24. Thorek, D.L.J., et al., Superparamagnetic iron oxide nanoparticle probes for molecular 
imaging. Annals of Biomedical Engineering, 2006. 34(1). 
25. Gupta, A.K. and A.S.G. Curtis, Surface modified superparamagnetic nanoparticles for drug 
delivery: Interaction studies with human fibroblasts in culture. Journal of Materials Science-
Materials in Medicine, 2004. 15(4). 
26. Zhang, Y., N. Kohler, and M.Q. Zhang, Surface modification of superparamagnetic magnetite 
nanoparticles and their intracellular uptake. Biomaterials, 2002. 23(7): p. 1553-1561. 
27. Chithrani, B.D. and W.C.W. Chan, Elucidating the mechanism of cellular uptake and removal 
of protein-coated gold nanoparticles of different sizes and shapes. Nano Letters, 2007. 7(6): 
p. 1542-1550. 
28. Jin, H., et al., Size-Dependent Cellular Uptake and Expulsion of Single-Walled Carbon 
Nanotubes: Single Particle Tracking and a Generic Uptake Model for Nanoparticles. Acs Nano, 
2009. 3(1): p. 149-158. 
29. Iversen, T.-G., T. Skotland, and K. Sandvig, Endocytosis and intracellular transport of 
nanoparticles: Present knowledge and need for future studies. Nano Today, 2011. 6(2). 
30. Gerets, H.H.J., et al., Characterization of primary human hepatocytes, HepG2 cells, and 
HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity 
for the detection of human hepatotoxins. Cell Biology and Toxicology, 2012. 28(2): p. 69-87. 
31. Kumar, M., et al., Cellular interaction of folic acid conjugated superparamagnetic iron oxide 
nanoparticles and its use as contrast agent for targeted magnetic imaging of tumor cells. 
International Journal of Nanomedicine, 2012. 7: p. 3503-3516. 
32. Instruments, M., Zeta sizer nano series. Vol. Issue 1.0 june. 2003. 
33. Anoopkumar-Dukie, S., et al., Resazurin assay of radiation response in cultured cells. British 
Journal of Radiology, 2005. 78(934): p. 945-947. 
34. Walkey, C.D., et al., Nanoparticle Size and Surface Chemistry Determine Serum Protein 
Adsorption and Macrophage Uptake. Journal of the American Chemical Society, 2012. 134(4). 
35. Chithrani, B.D., A.A. Ghazani, and W.C.W. Chan, Determining the size and shape dependence 
of gold nanoparticle uptake into mammalian cells. Nano Letters, 2006. 6(4): p. 662-668. 
36. Woods, J.T. and M.G. Mellon, Thiocyanate method for iron - A spectrophotometric study. 
Industrial and Engineering Chemistry-Analytical Edition, 1941. 13: p. 0551-0554. 
37. Viollier, E., et al., The ferrozine method revisited: Fe(II)/Fe(III) determination in natural 
waters. Applied Geochemistry, 2000. 15(6): p. 785-790. 
38. Marsich, E., et al., Biological response of hydrogels embedding gold nanoparticles. Colloids 
and Surfaces B-Biointerfaces, 2011. 83(2): p. 331-339. 
39. van Tiel, S.T., et al., Variations in labeling protocol influence incorporation, distribution and 
retention of iron oxide nanoparticles into human umbilical vein endothelial cells. Contrast 
Media & Molecular Imaging, 2010. 5(5). 
40. Zhang, C., et al., Silica- and alkoxysilane-coated ultrasmall superparamagnetic iron oxide 
particles: A promising tool to label cells for magnetic resonance imaging. Langmuir, 2007. 
23(3): p. 1427-1434. 
41. Naseem, U., Functionalized gold nanoparticles for specific genaration of oxidative stress, in 
Organic chemistry. 2012, Lund University. 
42. Fan, J.H., et al. Biocompatibility Study of Gold Nanoparticles to Human Cells. in 13th 
International Conference on Biomedical Engineering (ICBME). 2009. Singapore. 
45 
 
43. Matuszewski, L., et al., Cell tagging with clinically approved iron oxides: Feasibility and effect 
of lipofection, particle size, and surface coating on labeling efficiency. Radiology, 2005. 
235(1). 
44. Metz, S., et al., Capacity of human monocytes to phagocytose approved iron oxide MR 
contrast agents in vitro. European Radiology, 2004. 14(10). 
 
 
